Cargando…

Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases

Kynurenine‐3‐monooxygenase (KMO) is an enzyme that relies on nicotinamide adenine dinucleotide phosphate (NADP), a key site in the kynurenine pathway (KP), which has great effects on neurological diseases, cancer, and peripheral inflammation. This review mainly pay attention to the research of KMO m...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yifei, Shao, Mingmei, Wu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020307/
https://www.ncbi.nlm.nih.gov/pubmed/32148781
http://dx.doi.org/10.1002/fsn3.1418

Ejemplares similares